Friday, August 13, 2021

FDA solicits feedback on drug products approved under abbreviated new drug applications before the enactment of the Hatch-Waxman Amendments (Docket Closing Date Corrected)


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment